Objective To characterise the age-related impact of organ damage patterns on health-related quality of life (HRQoL) in ...

Objectives The European Alliance of Associations for Rheumatology (EULAR) recommendations for the management of systemic lupus erythematosus (SLE) and lupus nephritis provide important guidance for ...

In May, the German group that pioneered the treatment in rheumatic disease reported on a troubling syndrome they dubbed ...

Objective This study aimed to evaluate the prevalence and predictors of cardiovascular disease (CVD), chronic kidney disease ...

A multicentre retrospective study has found that chronic spontaneous urticaria (CSU) occurring in patients with systemic ...

Cambridge: AstraZeneca has announced that Saphnelo (anifrolumab) has been approved in the European Union (EU) for ...

Medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and ...

GLPG3667 met primary endpoint in dermatomyositis study, demonstrating a statistically significant clinical benefit and meaningful improvements on secondary measures of disease activity compared to pla ...

About GLPG3667, the GALARISSO (NCT: 05695950) and GALACELA (NCT: 05856448) studies GLPG3667 is an investigational reversible and selective tyrosine kinase 2 (TYK2) kinase domain inhibitor currently ...

A new study finds that experiences of discrimination are associated with worse patient-reported lupus-related symptoms and depressive symptoms among people with systemic lupus erythematosus (SLE).

The 15-44 age range of women faces elevated danger from this condition, which shows hereditary patterns because of both ...

SEN. Bong Go backed a measure that seeks to create a National Health Program to Combat Systemic Lupus Disease, emphasizing the importance of early diagnosis, prompt treatment and expanded financial ...